Videos

Rodica Di Lorenzo, MD, explains why new headaches, migraine with aura, estrogen exposure, smoking, and pregnancy matter in stroke assessment.

A urologist discusses how primary care clinicians can identify patients most likely to benefit from prostate cancer screening while limiting overdiagnosis.

Before any prescription is written, non-pharmacologic strategies and a structured framework guide the panel's approach to agitation, alongside a biological explanation for why redirection so often fails.

Agitation does not stay contained to the patient. The panel examines the data linking agitation to caregiver burden, and the communication gaps that complicate coordinating care across specialties.

Brief speech, motor, vision, or balance changes may signal a TIA and require urgent evaluation, Rodica Di Lorenzo, MD, tells Patient Care Online.

Rodica Di Lorenzo, MD, of the Cleveland Clinic, reviews hypertension, lipids, diabetes, smoking, atrial fibrillation, and wearables in first-stroke prevention.

In "Improving Shared Decision-Making in Endometriosis Care," the panel opens Section 3 by asking why medical management still lags in everyday practice.

Experts weigh GLP-1 therapy's promise for PMOS against the risks of overly rapid weight loss in teenagers.

Experts break down which labs actually change PMOS management and how to avoid diagnostic pitfalls.

Distinguishing agitation from depression, anxiety, and psychosis shapes everything that follows in treatment. The panel walks through the clinical differences and where formal screening scales genuinely fit into daily practice.

Agitation eventually affects nearly every patient with Alzheimer's disease, yet it rarely looks like simple aggression. The panel outlines how common it is, the many forms it takes, and why it so often goes unrecognized.

Most patients meet PMOS in a primary care office first. Our experts map the referral threshold and argue insulin resistance — not just androgens — should drive how aggressively PCPs treat.

Our expert panel walks through the 2-criteria threshold for adolescents, the "at risk" category, and why untreated menstrual irregularity carries real long-term consequences.

In "Monitoring Safety and Symptom Relief During Endometriosis Therapy," Dr. Davitt details the practical monitoring plan he follows once a patient begins therapy.

Expert faculty demonstrate how thoughtful screening and careful interpretation can help primary care clinicians recognize hypercortisolism earlier and with greater confidence.

This episode, "Add-Back Therapy: Balancing Efficacy and Safety in Endometriosis," features Dr. Davitt reviewing 12-month efficacy and safety data on add-back therapy.

A global consensus just renamed PCOS to PMOS. Our experts explain why the shift moves care beyond the ovaries — and what it means for how clinicians talk to patients today.

In "Long-Term Data on Relugolix Combination Therapy for Endometriosis Pain," the panel reviews two-year outcomes from a major open-label extension trial.

Recognizing hypercortisolism is only the first step. Expert faculty discuss how thoughtful evaluation, strong clinical advocacy, and coordinated referral can help patients receive timely diagnosis and appropriate care.

In "Choosing Between Newer GnRH Antagonist Therapies for Endometriosis," Dr. Davitt compares two newer, FDA-approved options for treating endometriosis-associated pain.

Expert faculty examine how resistant hypertension may signal underlying hypercortisolism and discuss when clinicians should think beyond routine blood pressure management.

Once-weekly insulin's longer half-life reshapes the hypoglycemia conversation, and trial data point to a bigger role for CGM in primary care.

New research links cardiovascular-kidney-metabolic health stage to measurable arterial injury in adults as young as 23, with obesity the leading driver.

Josef Coresh, MD, discusses biomarkers, hearing correction, and integrated vascular care as emerging dementia prevention strategies.

In "Comparing GnRH Agonists and Antagonists for Endometriosis Pain," Dr. Davitt explains the mechanistic split between two major drug classes used to manage endometriosis pain.

Expert faculty discuss how treatment outcomes and emerging evidence strengthen the case for earlier recognition of hypercortisolism in primary care.

Expert faculty demonstrate how practical hypercortisolism screening can be in primary care when clinicians know which test to use and how to use it.

In "Why Estrogen Suppression Anchors Endometriosis Treatment," the panel explores the biological rationale that makes estrogen suppression the backbone of medical therapy.

A nurse practitioner discusses why once-weekly basal insulin matters, who benefits most, and how its starting doses differ from daily insulin.

Josef Coresh, MD, PhD, discusses how primary care clinicians can address hypertension, diabetes, and smoking to support long-term cognitive health.